e-Edition
Obituaries
Special Sections
Special Occasions
Contact
Subscribe
Paywall Login
Login to Comment
Register
December 11th, 2017
jobs
homes
Menu
Home
News
Sports
Business
Entertainment
Classifieds
Commentary
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Beta Bionics, Inc. - Common Stock
(NQ:
BBNX
)
13.36
+0.04 (+0.30%)
Delayed Quote
Updated: 4:00 PM EST, Nov 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Beta Bionics, Inc. - Common Stock
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Senseonics and Beta Bionics Launch Eversense® 365 and iLet® Bionic Pancreas Integration
November 16, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Beta Bio: 3 Key Takeaways for Long-Term Investors
↗
November 09, 2026
A tubeless patch pump launch and pharmacy channel momentum could reshape the company's margin profile within three years.
Via
The Motley Fool
Topics
Earnings
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Beta Bionics, Inc. of Class Action Lawsuit and Upcoming Deadlines – BBNX
November 03, 2026
From
Pomerantz LLP
Via
GlobeNewswire
BBNX Deadline Today: Rosen Law Firm Urges Beta Bionics, Inc. (NASDAQ: BBNX) Stockholders to Contact the Firm for Information About Their Rights
November 03, 2026
From
The Rosen Law Firm, P.A.
Via
Business Wire
Beta Bionics (NASDAQ:BBNX) Slides After Q3 Results as Guidance and Product Timing Weigh
↗
October 27, 2026
Via
Chartmill
SueWallSt Reminds Shareholders of a Lead Plaintiff Deadline of November 3, 2026 in Beta Bionics, Inc. Lawsuit - BBNX
November 03, 2026
The lawsuit contends Beta Bionics abandoned a built-in safety net for the iLet dosing algorithm and left more than 18,000 customer complaints uninvestigated, alleged operational failures that reached...
From
SueWallSt
Via
GlobeNewswire
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds Beta Bionics (NASDAQ: BBNX) Investors of Securities Class Action Lawsuit Deadline on November 3, 2026
November 03, 2026
From
Faruqi & Faruqi, LLP
Via
Business Wire
Beta Bionics Announces Participation at Upcoming Investor Conferences
November 03, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Beta Bionics (NASDAQ: BBNX) Investors of Securities Class Action Lawsuit Deadline on November 3, 2026
November 02, 2026
From
Faruqi & Faruqi LLP
Via
GlobeNewswire
Kaplan Fox Reminds Beta Bionics, Inc. (NASDAQ: BBNX) Investors of an Approaching Securities Class Action Deadline on November 3, 2026
November 02, 2026
From
Kaplan Fox & Kilsheimer, LLP
Via
GlobeNewswire
Levi & Korsinsky Reminds Beta Bionics, Inc. Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of November 3, 2026 - BBNX
November 02, 2026
Important information regarding Section 20(a) individual liability claims: the lawsuit alleges Beta Bionics' CEO and CFO certified SEC filings while a June 2025 FDA Form 483 citing more than 18,000...
From
Levi & Korsinsky, LLP
Via
GlobeNewswire
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit
November 02, 2026
From
Schall, Brown & Schwartz LLP
Via
GlobeNewswire
BBNX DEADLINE TUESDAY: Bragar Eagel & Squire, P.C. Reminds Beta Bionics, Inc. Investors They Have Until November 3rd to Seek Lead Plaintiff Role with the Firm
October 31, 2026
From
Bragar Eagel & Squire
Via
GlobeNewswire
Beta Bionics 96 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against Beta Bionics, Inc. - BBNX
October 30, 2026
From
Kahn Swick & Foti, LLC
Via
Business Wire
Kaplan Fox Alerts Investors of Beta Bionics, Inc. (NASDAQ: BBNX) to an Upcoming Deadline of November 3, 2026 in the Securities Class Action
October 30, 2026
From
Kaplan Fox & Kilsheimer, LLP
Via
GlobeNewswire
BBNX UPCOMING DEADLINE: Levi & Korsinsky Alerts Beta Bionics, Inc. Stockholders of Securities Class Action - Contact the Firm
October 30, 2026
From
Levi & Korsinsky, LLP
Via
ACCESS Newswire
Beta Bionics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Beta Bionics, Inc. - BBNX
October 29, 2026
From
SkyMedia, LLC
Via
GlobeNewswire
Kaplan Fox Alerts Beta Bionics, Inc. (NASDAQ: BBNX) Investors of Substantial Losses to a Securities Class Action - Critical Deadline is November 3, 2026
October 29, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
BBNX Investor Alert: Schall, Brown & Schwartz LLP Files Class Action Lawsuit Against Beta Bionics, Inc. and Announces Opportunity for Investors to Lead Class Action Lawsuit
October 29, 2026
From
Schall, Brown & Schwartz LLP
Via
GlobeNewswire
Kaplan Fox Notifies Beta Bionics, Inc. (NASDAQ: BBNX) Investors of a Securities Class Action Lawsuit – Deadline is November 3, 2026
October 28, 2026
From
Kaplan Fox & Kilsheimer, LLP
Via
GlobeNewswire
BETA BIONICS, INC. INVESTORS WITH LOSSES HAVE UNTIL NOVEMBER 3, 2026 TO JOIN SECURITIES CLASS ACTION – Bernstein Liebhard LLP Announces Deadline
October 28, 2026
From
Bernstein Liebhard LLP
Via
GlobeNewswire
Beta Bionics (BBNX) Q3 2026 Earnings Call Transcript
↗
October 28, 2026
Revenue hit $35.5 million with 30% growth as Mint patch pump nears Q1 2027 launch.
Via
The Motley Fool
Topics
Earnings
Beta Bionics, Inc. Notice of November 3, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline
October 27, 2026
From
Kahn Swick & Foti, LLC
Via
GlobeNewswire
Beta Bionics Q3 Earnings Call Highlights
↗
October 27, 2026
Beta Bionics (NASDAQ:BBNX) reported third-quarter net sales of $35.5 million, up about 30% from a year earlier, as new patient starts and recurring revenue from its pharmacy-channel user base supported...
Via
MarketBeat
Topics
Earnings
After-Hours Market Movers for Oct. 27, 2026: Gainers and Losers
↗
October 27, 2026
Via
Chartmill
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Beta Bionics, Inc. of Class Action Lawsuit and Upcoming Deadlines – BBNX
October 27, 2026
From
Pomerantz LLP
Via
GlobeNewswire
Beta Bionics Announces Third Quarter 2026 Financial Results and Updates Full Year 2026 Guidance
October 27, 2026
From
Beta Bionics, Inc.
Via
GlobeNewswire
Bragar Eagel & Squire, P.C. Reminds Beta Bionics, Inc. Investors They Have Until November 3rd to Seek Lead Plaintiff Role with The Firm
October 27, 2026
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Beta Bionics (BBNX) To Contact Him Directly To Discuss Their Options
From
Bragar Eagel & Squire
Via
GlobeNewswire
Kaplan Fox Notifies Beta Bionics, Inc. (NASDAQ: BBNX) Investors of a Pending Securities Class Action Deadline on November 3, 2026
October 27, 2026
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
BBNX Investor Alert: Beta Bionics, Inc. Securities Class Action Notice - Contact SueWallSt
October 27, 2026
A securities class action alleges Beta Bionics kept a June 2025 FDA Form 483 and more than 18,000 unreported iLet complaints out of public view for months, with the dates of each disclosure tracking a...
From
SueWallSt
Via
GlobeNewswire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.